THAÇI, Diamant et al. Absolute Eczema Area and Severity Index Responses with Lebrikizumab in Patients with Moderate-to-severe Atopic Dermatitis: A Secondary Analysis of Two Phase 3 Trials. Acta Dermato-Venereologica, [S. l.], v. 106, p. adv–2025, 2026. DOI: 10.2340/actadv.v106.adv-2025-0160. Disponível em: https://medicaljournalssweden.se/actadv/article/view/46159. Acesso em: 26 may. 2026.